Emergent Medical Partners, LLP — 2017 Investments
1 investments dated 2017 · listed companies and verified rows first · show all
Intervene Incintervene-med.comMay 2017SEC filingmedium confidence
InterVene, Inc. is a medical device company that has developed a fully integrated mechanical thrombectomy system to treat venous in-stent restenosis and residual thrombotic venous obstructions and occlusions.
BiotechHealthtechMedical DevicesMountain View, US
Fletcher Wilson(Executive Officer, Director)
BoardThomas Fogarty(Director)Mel Schatz(Director)
Board seatThomas J. Fogarty· per SEC Form D · $3M raise · filed Jun 2017
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.